Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System

Timil Patel, Joseph Miccio, Michael Cecchini, Thejal Srikumar, Stacey Stein, Jeremy Kortmanksy, Kimberly Johung, Jill Lacy

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System'. Together they form a unique fingerprint.

Medicine & Life Sciences